Get the Stockscreener App
7.14
1.31%
0.08
Inventiva Adr stock is traded at $7.14, with a volume of 248.23K.
It is up +1.31% in the last 24 hours and up +63.31% over the past month.
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
See More
Previous Close:
$7.06
Open:
$7.18
24h Volume:
248.23K
Relative Volume:
0.63
Market Cap:
$1.37B
Revenue:
$9.96M
Net Income/Loss:
$-199.33M
P/E Ratio:
-2.1425
EPS:
-3.3326
Net Cash Flow:
$-93.38M
1W Performance:
+9.87%
1M Performance:
+63.31%
6M Performance:
+115.45%
1Y Performance:
+183.84%
1-Day Range:
$7.11
$7.26
1-Week Range:
$5.92
$7.26
52-Week Range:
$2.1513
$7.9825
Inventiva Adr Stock (IVA) Company Profile
Compare IVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
7.15 | 1.35B | 9.96M | -199.33M | -93.38M | -3.3326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.63 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.66 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
831.39 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.25 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
341.01 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-07-26 | Resumed | UBS | Buy |
| Nov-06-25 | Initiated | Wolfe Research | Outperform |
| Sep-03-25 | Resumed | H.C. Wainwright | Buy |
| Aug-27-25 | Initiated | Piper Sandler | Overweight |
| Feb-21-25 | Initiated | TD Cowen | Buy |
| Nov-12-24 | Initiated | UBS | Neutral |
| Oct-27-23 | Initiated | Canaccord Genuity | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-19-23 | Upgrade | Societe Generale | Sell → Buy |
| Mar-17-23 | Initiated | Stifel | Buy |
| Nov-15-22 | Downgrade | Societe Generale | Buy → Sell |
| Mar-08-21 | Downgrade | Societe Generale | Buy → Sell |
| Aug-05-20 | Initiated | ROTH Capital | Buy |
| Aug-04-20 | Initiated | Guggenheim | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Inventiva Adr Stock (IVA) Latest News
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update - MarketBeat
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva’s (IVA) “Buy” Rating Reiterated at UBS Group - Defense World
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know - primepublishers.com
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeHere's Why - MarketBeat
The time has not yet come to remove your chips from the table: Inventiva ADR (IVA) - setenews.com
Debt to assets ratio of Inventiva SA ADR – LSX:A2P796 - TradingView — Track All Markets
Net margin % of Inventiva SA ADR – LSX:A2P796 - TradingView
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025 - GlobeNewswire Inc.
Weekly Investment Analysts’ Ratings Changes for Inventiva (IVA) - Defense World
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Inventiva (NASDAQ:IVA) Price Target Cut to $11.00 by Analysts at Guggenheim - Defense World
ETFs Investing in Inventiva SA ADR Stocks - TradingView
Form 424B5 Inventiva S.A. - StreetInsider
Its Stock Has Paid Off Big Time For Inventiva ADR - Setenews
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Upgraded at Wolfe Research - Defense World
Assemblée Générale Mixte du 27 novembre 2025 - GlobeNewswire Inc.
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Up 461.9% in October - MarketBeat
How Does Wall Street Rate Shares Of Inventiva ADR (IVA)? - fostersleader.com
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Inventiva (NASDAQ:IVA) Raised to “Hold” at Wall Street Zen - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Inventiva Stock Falls 9% Following Announcement of a Dilutive Financing Program - Idéal Investisseur
FY2025 EPS Estimates for Inventiva Cut by HC Wainwright - MarketBeat
Why You Need Galapagos NV ADR (GLPG) On Your Watchlist - fostersleader.com
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Inventiva Stock Price, Quotes and Forecasts | NASDAQ:IVA - Benzinga
Inventiva (NASDAQ:IVA) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Inventiva (NASDAQ:IVA) Shares Gap DownTime to Sell? - MarketBeat
Inventiva SA Reports Progress and Challenges in 2025 - TipRanks
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Inventiva (NASDAQ:IVA) Shares Gap UpHere's What Happened - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $14.83 Average Target Price from Analysts - Defense World
Brokerages Set Inventiva S.A. Sponsored ADR (NASDAQ:IVA) PT at $14.83 - MarketBeat
IVA Price History for Inventiva S.A. ADR Stock - Barchart.com
Inventiva Adr Stock (IVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.74%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):